Difficulty: Medium
Average Score: 94%
Practice
Which of the following agents is a short-acting ganglion blocker?
Correct answer
B
Rationale
In pharmacological lifespan treatment, understanding the properties of various agents is crucial for effective patient care. The correct answer is B) Trimethaphan, a short-acting ganglion blocker. Ganglion blockers act on autonomic ganglia to block both sympathetic and parasympathetic pathways. Trimethaphan is particularly short-acting, making it useful in situations where rapid reversal of its effects may be necessary.
Option A) Homatropine is a muscarinic antagonist used for its mydriatic effect in ophthalmic exams, not as a ganglion blocker.
Option C) Hexamethonium is a ganglion blocker, but it has a longer duration of action compared to Trimethaphan, making it the incorrect answer in this context.
Option D) Pancuronium is a neuromuscular blocker used in anesthesia for muscle relaxation during surgery, not as a ganglion blocker.
Educationally, this question reinforces the importance of differentiating between various classes of medications, understanding their mechanisms of action, and recognizing their specific uses in clinical practice. It highlights the need for precision in drug selection based on pharmacological properties to achieve desired therapeutic outcomes.
Option A) Homatropine is a muscarinic antagonist used for its mydriatic effect in ophthalmic exams, not as a ganglion blocker.
Option C) Hexamethonium is a ganglion blocker, but it has a longer duration of action compared to Trimethaphan, making it the incorrect answer in this context.
Option D) Pancuronium is a neuromuscular blocker used in anesthesia for muscle relaxation during surgery, not as a ganglion blocker.
Educationally, this question reinforces the importance of differentiating between various classes of medications, understanding their mechanisms of action, and recognizing their specific uses in clinical practice. It highlights the need for precision in drug selection based on pharmacological properties to achieve desired therapeutic outcomes.